Use of an Aedes Salivary Biomarker to Assess Arboviral disease Transmission Risk in Northern Tanzania
TMA2019PF-2694
EDCTP2
EDCTP-AREF Preparatory Fellowships (PF)
To determine human exposure to Aedes mosquitoes as measured by specific anti-IgG antibodies against Aedes Nterm-34kDa salivary peptide, and to assess whether level of antibodies could be useful in assessing the risk of dengue, Zika and chikungunya transmission and evaluate efficacy of vector control strategies in North-Eastern Tanzania.
The study will be conducted in three villages in Bondo site, Tanga. Surveys will be conducted three Vector control will be performed few days after the T1 visit. A total of 362 participants will be enrolled.. Participants will be followed longitudinally to screen level of ant- IgG antibody response against Aedes salivary gland peptides
Aedes-borne diseases represents a major worldwide public health challenge, especially in tropical and subtropical regions. Among the most important Aedes-borne diseases includes dengue, Zika, Yellow fever and Chikungunya that can cause a hemorrhagic fever, Shock syndrome, chronic joint pain, microcephaly and multi-system failure. The study intends to study human exposure to Aedes mosquitoes as measured by specific anti-IgG antibodies and to assess whether level of antibodies could be useful in assessing the risk of dengue, Zika and chikungunya transmission and evaluate efficacy of vector control strategies in North-Eastern Tanzania. Data collected in this study will uncover the risk of arboviral transmission in north eastern Tanzania. Data generated will provide an early warning of increased risk of transmission of arboviral disease and early warning signs of outbreaks to allocate public health interventions.
Department | Institution | Country |
---|---|---|
Microbiology and Parasitology | Centre for Research in Infectious Diseases (CRID), Yaoundé, | Cameroon |